{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:47:28Z","timestamp":1783770448607,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.prro.2024.12.005","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T16:55:25Z","timestamp":1735318525000},"page":"387-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radiopharmaceutical and Radioembolization Therapy: Clinical Guidance for Medical Physicists in Radiation Oncology"],"prefix":"10.1016","volume":"15","author":[{"given":"Jonathan A.","family":"Polignani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2024.12.005_bib0001","unstructured":"Society of Nuclear Medicine and Molecular Imaging. Historical Timeline - SNMMI. www.snmmi.org. Accessed March 2, 2024.https:\/\/www.snmmi.org\/AboutSNMMI\/Content.aspx?ItemNumber=4175"},{"key":"10.1016\/j.prro.2024.12.005_bib0002","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijrobp.2022.08.010","article-title":"A Primer on Radiopharmaceutical Therapy","volume":"115","author":"Salerno","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.12.005_bib0003","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2967\/jnumed.118.220665","article-title":"Theranostics: Leveraging molecular imaging and therapy to impact patient management and secure the future of nuclear medicine","volume":"61","author":"Solnes","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2024.12.005_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semradonc.2020.07.001","article-title":"The rapid evolution of theranostics in radiation oncology","volume":"31","author":"Buatti","year":"2021","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.prro.2024.12.005_bib0005","unstructured":"National Cancer Institute. Radiopharmaceuticals Emerging as New Cancer Therapy - National Cancer Institute. www.cancer.gov. Published October 26, 2020. https:\/\/www.cancer.gov\/news-events\/cancer-currents-blog\/2020\/radiopharmaceuticals-cancer-radiation-therapy"},{"key":"10.1016\/j.prro.2024.12.005_bib0006","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ijrobp.2020.11.048","article-title":"A framework for patient-centered pathways of care for radiopharmaceutical therapy: An ASTRO consensus document","volume":"109","author":"Buatti","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.12.005_bib0007","unstructured":"ASTRO. ASTRO Winter 2023 Newsletter: Radiopharmaceuticals.; 2023. Accessed December 16, 2023.https:\/\/www.astro.org\/ASTRO\/media\/ASTRO\/News%20and%20Publications\/ASTROnews\/PDFs\/2023_Winter_ASTROnews.pdf"},{"key":"10.1016\/j.prro.2024.12.005_bib0008","article-title":"Unsealed source: scope of practice for radiopharmaceuticals among United States radiation oncologists","volume":"7","author":"Shukla","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2024.12.005_bib0009","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2022.03.018","article-title":"ASTRO's Framework for Radiopharmaceutical Therapy Curriculum Development for Trainees","volume":"113","author":"Kiess","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.12.005_bib0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijrobp.2020.09.029","article-title":"US radiation oncologists (Re)Defined: An American Society for Radiation Oncology scope of practice study","volume":"109","author":"Fung","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.12.005_bib0011","unstructured":"FDA. FDA Labels.; Note: Radiopharmaceutical therapy labels for therapies listed in Table 2. Accessed December 16, 2023. https:\/\/labels.fda.gov\/"},{"key":"10.1016\/j.prro.2024.12.005_bib0012","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1118\/1.3608909","article-title":"Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90 Y microsphere brachytherapy in the treatment of hepatic malignancies","volume":"38","author":"Dezarn","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2024.12.005_bib0013","doi-asserted-by":"crossref","first-page":"e14157","DOI":"10.1002\/acm2.14157","article-title":"AAPM Medical Physics Practice Guideline 14.a: Yttrium-90 microsphere radioembolization","volume":"25","author":"Busse","year":"2024","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.prro.2024.12.005_bib0014","doi-asserted-by":"crossref","unstructured":"Macey DJ, Williams LE, Breitz HB, Liu A, Johnson TK, Zanzonico P. Report No. 071 - A Primer for Radioimmunotherapy and Radionuclide Therapy (2001). Accessed December 12, 2024. https:\/\/www.aapm.org\/pubs\/reports\/detail.asp?docid=70","DOI":"10.37206\/70"},{"key":"10.1016\/j.prro.2024.12.005_bib0015","doi-asserted-by":"crossref","unstructured":"Nickoloff EL, Strauss KJ, Austin B, et al. Report of AAPM TG-181: The selection, use, calibration, and quality assurance of radionuclide calibrators used in nuclear medicine (2012). Accessed December 12, 2024. https:\/\/www.aapm.org\/pubs\/reports\/rpt_181.pdf","DOI":"10.37206\/137"},{"key":"10.1016\/j.prro.2024.12.005_bib0016","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2967\/jnumed.107.050203","article-title":"Routine quality control of clinical nuclear medicine instrumentation: A brief review","volume":"49","author":"Zanzonico","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2024.12.005_bib0017","series-title":"Physics in Nuclear Medicine","author":"Cherry","year":"2012"},{"key":"10.1016\/j.prro.2024.12.005_bib0018","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2967\/jnmt.107.044156","article-title":"Procedure guideline for the use of radiopharmaceuticals 4.0","volume":"35","author":"Callahan","year":"2007","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.prro.2024.12.005_bib0019","first-page":"856","article-title":"Procedure guideline for therapy of thyroid disease with 131Iodine","volume":"43","author":"Meier","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2024.12.005_bib0020","doi-asserted-by":"crossref","first-page":"e13899","DOI":"10.1002\/acm2.13899","article-title":"Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium-177 prostate-specific membrane antigen (PSMA) therapy","volume":"24","author":"Zoberi","year":"2023","journal-title":"J Appl Clin Med Phys"},{"key":"#cr-split#-10.1016\/j.prro.2024.12.005_bib0021.1","unstructured":"NCRP. NCRP Report No. 155: Management of radionuclide therapy patients (2006). National Council On Radiation Protection and Measurements"},{"key":"#cr-split#-10.1016\/j.prro.2024.12.005_bib0021.2","unstructured":"2007. Accessed December 12, 2024.https:\/\/ncrponline.org\/shop\/reports\/report-no-155-management-of-radionuclide-therapy-patients-2006\/#:\u223c:text=This%20Report%20makes%20recommendations%20on,and%20activity%20used%2C%20the%20treating"},{"key":"10.1016\/j.prro.2024.12.005_bib0022","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0146645319838665","article-title":"ICRP Publication 140: Radiological protection in therapy with radiopharmaceuticals","volume":"48","author":"Yonekura","year":"2019","journal-title":"Ann ICRP"},{"key":"10.1016\/j.prro.2024.12.005_bib0023","unstructured":"U.S. Nuclear Regulatory Commission. NUREG-1556, Vol 9-Consolidated Guidance About Materials Licenses Program: Specific Guidance About Medical Use Licenses. Published September 2019. Accessed December 2023.https:\/\/www.nrc.gov\/docs\/ML1925\/ML19256C219.pdf"},{"key":"10.1016\/j.prro.2024.12.005_bib0024","unstructured":"Clements J, King S, Geise R, Lieto R, Hasselquist B, Martin M. ACR-AAPM Radiation Safety Officer Resources Essential Information for Radiation Safety Officers at Medical Imaging Facilities. American College of Radiology American Association of Physicists in Medicine; 2021. Accessed December 12, 2024. https:\/\/www.acr.org\/-\/media\/ACR\/Files\/Radiology-Safety\/Radiation-Safety\/ACRAAPM-RSO-Resources.pdf?la=en"},{"key":"10.1016\/j.prro.2024.12.005_bib0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: Clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.prro.2024.12.005_bib0027","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ijrobp.2020.08.035","article-title":"Current Status of Radiopharmaceutical Therapy","volume":"109","author":"St. James","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.12.005_bib0026","unstructured":"National Nuclear Data Center, Brookhaven National Laboratory, United States Department of Energy. NuDat 3.0. Accessed April 26, 2024. https:\/\/www.nndc.bnl.gov"},{"key":"10.1016\/j.prro.2024.12.005_bib0028","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2967\/jnumed.121.262305","article-title":"Dosimetry in radiopharmaceutical therapy","volume":"63","author":"O'Donoghue","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2024.12.005_bib0029","unstructured":"US Nuclear Regulatory Commission. NRC Regulations Title 10, Code of Federal Regulations (NRC 10 CFR). Accessed December 16, 2023.https:\/\/www.nrc.gov\/reading-rm\/doc-collections\/cfr\/index.html"},{"issue":"Supplement 3","key":"10.1016\/j.prro.2024.12.005_bib0030","doi-asserted-by":"crossref","first-page":"3S11S","DOI":"10.2967\/jnumed.121.262749","article-title":"Dosimetry for radiopharmaceutical therapy: Current practices and commercial resources","volume":"62","author":"Capala","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2024.12.005_bib0031","first-page":"1587","article-title":"Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer","volume":"47","author":"Tuttle","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2024.12.005_bib0032","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2967\/jnumed.117.192278","article-title":"Alternative means of estimating 131I maximum permissible activity to treat thyroid cancer","volume":"58","author":"Nichols","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2024.12.005_bib0033","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejmp.2019.09.236","article-title":"A guide to 90Y radioembolization and its dosimetry","volume":"68","author":"Kim","year":"2019","journal-title":"Phys Med"},{"key":"10.1016\/j.prro.2024.12.005_bib0034","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1148\/rg.2020200021","article-title":"Theranostics in nuclear medicine: emerging and re-emerging integrated imaging and therapies in the era of precision oncology","volume":"40","author":"Gomes Marin","year":"2020","journal-title":"Radiographics"},{"key":"10.1016\/j.prro.2024.12.005_bib0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2967\/jnumed.108.056036","article-title":"MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry\u2013standardization of nomenclature","volume":"50","author":"Bolch","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2024.12.005_bib0036","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/jpm12020205","article-title":"Personalized dosimetry in targeted radiation therapy: A look to methods, tools and critical aspects","volume":"12","author":"Danieli","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.prro.2024.12.005_bib0037","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2967\/jnumed.122.264225","article-title":"MIRD Pamphlet No. 28, Part 1: MIRDcalc\u2014a software tool for medical internal radiation dosimetry","volume":"64","author":"Kesner","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.prro.2024.12.005_bib0038","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1118\/1.597316","article-title":"Comprehensive QA for radiation oncology: Report of AAPM Radiation Therapy Committee Task Group 40","volume":"21","author":"Kutcher","year":"1994","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2024.12.005_bib0039","unstructured":"National Commission on Radiation Protection (NCRP). Report No. 112 \u2013 Calibration of Survey Instruments Used in Radiation Protection for the Assessment of Ionizing Radiation Fields and Radioactive Surface Contamination (1991). Accessed December 12, 2024. https:\/\/ncrponline.org\/shop\/reports\/report-no-112-calibration-of-survey-instruments-used-in-radiation-protection-for-the-assessment-of-ionizing-radiation-fields-and-radioactive-surface-contamination-1991\/"},{"key":"10.1016\/j.prro.2024.12.005_bib0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1118\/1.598232","article-title":"High dose-rate brachytherapy treatment delivery: Report of the AAPM Radiation Therapy Committee Task Group No. 59","volume":"25","author":"Kubo","year":"1998","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2024.12.005_bib0041","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1002\/mp.15116","article-title":"Electronic charting of radiation therapy planning and treatment: Report of Task Group 262","volume":"48","author":"Mechalakos","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2024.12.005_bib0042","unstructured":"ACR\u2013AAPM\u2013ACNM\u2013SNMMI\u2013SPR. TECHNICAL STANDARD FOR THERAPEUTIC PROCEDURES USING RADIOPHARMACEUTICALS. Published 2022. Accessed May 16, 2024. https:\/\/www.acr.org\/-\/media\/ACR\/Files\/Practice-Parameters\/RadioPharm.pdf"},{"key":"10.1016\/j.prro.2024.12.005_bib0043","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1120\/jacmp.v16i3.5431","article-title":"Medical physics practice guideline 4.a: Development, implementation, use and maintenance of safety checklists","volume":"16","author":"de los Santos","year":"2015","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.prro.2024.12.005_bib0044","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.prro.2022.04.006","article-title":"Introduction to radiopharmaceutical therapy","volume":"12","author":"O'Brien","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2024.12.005_bib0045","unstructured":"US Nuclear Regulatory Commission. Regulatory Guide 8.39 Revision 1: Release of Patients Administered Radioactive Material.; Published April 2020. Accessed December 2023. https:\/\/www.nrc.gov\/docs\/ML1923\/ML19232A081.pdf"},{"key":"10.1016\/j.prro.2024.12.005_bib0046","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1118\/1.4947547","article-title":"The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management","volume":"43","author":"Huq","year":"2016","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2024.12.005_bib0047","series-title":"US NRC Memorandum on Licensing of Lutetium-177","author":"Clark","year":"2018"},{"key":"10.1016\/j.prro.2024.12.005_bib0048","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/HP.0000000000001644","article-title":"Clinical best practices for radiation safety during lutetium-177 therapy","volume":"124","author":"Cappon","year":"2022","journal-title":"Health Phys"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024003576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024003576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T10:01:00Z","timestamp":1750672860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850024003576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1879850024003576"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2024.12.005","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiopharmaceutical and Radioembolization Therapy: Clinical Guidance for Medical Physicists in Radiation Oncology","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2024.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}